MedPath

Parathyroid hormone

Generic Name
Parathyroid hormone
Brand Names
Natpara, Natpar
Drug Type
Biotech
CAS Number
9002-64-6
Unique Ingredient Identifier
N19A0T0E5J

Overview

Parathyroid hormone (PTH) is a single-chain polypeptide composed of 84 amino acids. Available as Preotact, it is an identical form of human recombinant hormome which produced as a fusion protein undergoeing post-translational processing involving the cleavage of the OmpA leader sequence, leaving the mature protein as a single-chain 84 amino-acids polypeptide (9.4 kDa). Preotact is used in the treatment of osteoporosis in postmenopausal women at high risk of osteoporotic fractures and is marketed in Europe by Nycomed. Preos is a registered trade mark owned by NPS Pharmaceuticals, Inc. The name Preos and the New Drug Application is pending approval by the U.S. Food and Drug Administration (FDA).

Background

Parathyroid hormone (PTH) is a single-chain polypeptide composed of 84 amino acids. Available as Preotact, it is an identical form of human recombinant hormome which produced as a fusion protein undergoeing post-translational processing involving the cleavage of the OmpA leader sequence, leaving the mature protein as a single-chain 84 amino-acids polypeptide (9.4 kDa). Preotact is used in the treatment of osteoporosis in postmenopausal women at high risk of osteoporotic fractures and is marketed in Europe by Nycomed. Preos is a registered trade mark owned by NPS Pharmaceuticals, Inc. The name Preos and the New Drug Application is pending approval by the U.S. Food and Drug Administration (FDA).

Indication

For use/treatment in osteoporosis.

Associated Conditions

  • Hypocalcemia
  • Hypoparathyroidism

FDA Approved Products

NATPARA (parathyroid hormone)
Manufacturer:Takeda Pharmaceuticals America, Inc.
Route:SUBCUTANEOUS
Strength:75 ug in 0.08 mL
Approved: 2023/02/28
NDC:68875-0204
NATPARA (parathyroid hormone)
Manufacturer:Takeda Pharmaceuticals America, Inc.
Route:SUBCUTANEOUS
Strength:100 ug in 0.08 mL
Approved: 2023/02/28
NDC:68875-0205
NATPARA (parathyroid hormone)
Manufacturer:Takeda Pharmaceuticals America, Inc.
Route:SUBCUTANEOUS
Strength:25 ug in 0.08 mL
Approved: 2023/02/28
NDC:68875-0202
NATPARA (parathyroid hormone)
Manufacturer:Takeda Pharmaceuticals America, Inc.
Route:SUBCUTANEOUS
Strength:50 ug in 0.08 mL
Approved: 2023/02/28
NDC:68875-0203

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath